/PRNewswire/ Nuance Pharma ("the Company") announces dosing of first patient in the ENHANCE - China Phase III Trial for the maintenance treatment of chronic.
COPENHAGEN, Denmark, February 15, 2023 - Bavarian Nordic A/S (OMX: BAVA) announced today its financial guidance for 2023 and provided an update on its late-stage pipeline programs. "We are looking
Shanghai Fosun Pharma announced it has licensed US rights to a PD-1 candidate from its longstanding partner Henlius Biotech in an $840 million agreement. Read more here.
Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.